TRANSABDOMINAL AND TRANSRECTAL ULTRASOUND ASSESSMENT OF INTRAVESICAL PROSTATIC PROTRUSION
- Authors: Krivoborodov G.G1,2, Efremov N.S1,2, Bolotov A.D1,2
-
Affiliations:
- N.I. Pirogov RNRMU of Minzdrav of Russia
- Russian Gerontology Research and Clinical Center
- Issue: No 6 (2017)
- Pages: 55-58
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/322087
- DOI: https://doi.org/10.18565/urology.2017.6.55-58
- ID: 322087
Cite item
Open Access
Access granted
Abstract
Relevance. Benign prostatic hyperplasia (BPH) is one of the most common urological diseases among men. Despite the noticeable positive effects of pharmacotherapy on the quality of urination in BPH, the presence of an intravesical obstruction (IVO) leads to discontinuation of conservative treatment in favor of surgical interventions. One of the features of prostate enlargement is the degree of its intravesical growth (intravascular prostatic protrusion, IPP). According to some studies, IPP value of 10 mm or more is indicative of IVO in virtually all men. Aim. To compare transabdominal and transrectal ultrasound measurement of IPP in men with BPH. Materials and methods. The study comprised 108 men aged 69±10 years (43 to 93 years) with lower urinary tract symptoms and BPH. Patients underwent a standard urological examination. The shape of the prostate, prostate volume and the measurements of the IPP were assessed using transabdominal and transrectal ultrasound. Results. The IPP measurements obtained using transabdominal and transrectal ultrasound were 9.8±5.7 mm (1.1 to 28 mm) and 9.3±5.3 mm (0.5 to 26 mm), respectively. The IPP measurements evaluated by transabdominal and transrectal ultrasound were found comparable regardless of the prostate volume. Conclusion. Similar results in assessing PPI by both ultrasound modalities allow them to be used equally effectively.
Full Text
About the authors
G. G Krivoborodov
N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center
Email: dr.krivoborodov@yandex.ru
Dr.Med.Sci., Prof. at the Department of Urology and Andrology; Head of the Department of Urology Moscow, Russia
N. S Efremov
N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center
Email: nefr@yandex.ru
Ph.D., Associate Professor at the Department of Urology and Andrology; Urologist Moscow, Russia
A. D Bolotov
N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center
Email: adbolotov@gmail.com
Ph.D. Student at the Department of Urology and Andrology; Urologist Moscow, Russia
References
- Agarwal A., Eryuzlu L.N., Cartwright R., Thorlund K., Tammela, T.L., Guyatt G.H., Auvinen A., Tikkinen K.A. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur.Urol. 2014;65(6): 1211-17. Doi: 10.1016/j. eururo.2014.01.019.
- Roehrborn C.G., Cruz F., Fusco F. a1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different? Adv.Ther. 2017;33(12):2110-21. doi: 10.1007/s12325-016-0423-5.
- Puushkar D.Yu., Rasner P.I. Experience in administration of cholinolytics in the treatment of patients with prostatic adenoma and symptoms of the lower urinary tract. Urologiia. 2011;2:80-85.
- Mazo E.B. Pharmacotherapy of benign prostatic hyperplasia. Consilium Medicum. 2003;7(5):392-396. Russian. (Мазо Е.Б. Фармакотерапия доброкачественной гиперплази и простаты. Consilium Medicum. 2003;7(5):392-396).
- Alyaev Yu.G., Grigoriev N.A., Lokshin K.L., Dymov A.M. Holmium laser enucleation of the prostate (HoLEP) in a benign prostatic hyperplasia treatment. Med. VestnikBashkortostana. 2010;6(5): 19-23.
- Ohnuki T., Kurokawa K., Katoh N., Fukabori Y., Shimizu K., Nakai K., Yamanaka H. Transrectal longitudinal ultrasonography of the prostate by electronic linear scanning. Hinyokika Kiyo. 1987;33(9):1385-1388.
- Chia S.J., Heng C.T., Chan S.P., Foo K.T. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU. Int. 2003;91(4):371-374.
- Krivoborodov G.G., Efremov N.S., Bolotov A.D. Intravesical prostatic protrusion in diagnosing infravesical obstruction in men with benign prostatic hyperplasia. Urologiia. 2017;2:105-109
- Tan Y.H., Foo K.T. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J.Urol. 2003;170(6 Pt 1):2339-2341. doi: 10.1097/01.ju.0000095474.86981.00.
- Lee L.S., Sim H.G., Lim K.B., Wang D., Foo K.T. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int.J.Urol. 2010;17(1):69-74. doi: 10.1111/j.1442-2042.2009.02409.x.
- Nose H., Foo K.T., Lim K.B., Yokoyama T., Ozawa H., Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology. 2005;65(3):493-497. doi: 10.1016/j.urology.2004.10.014.
- Moul S., McVary K.T. Lower urinary tract symptoms, obesity and the metabolic syndrome. Curr.Opin.Urol. 2010;20:7-12. Doi: 10.1097/ MOU.0b013e3283336f3f.
- Razina A.O., Runenko S.D., Achkasov E.E. Obesity: Current Global and Russian Trends. Annals of the Russian academy of medical sciences. 2016;71(2): 154-159.
- Kaplan S.A., Bowers D.L., Te A.E., Olsson C.A. Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy. J.Urol. 1996;155(4):1305-1308.
- Kalkanli A., Tandogdu Z., Aydin M., Karaca A.S., Hazar A.I., Balci M.B., Aydin M., Nuhoglu B. Intravesical prostatic protrusion: a potential marker of alpha-blocker treatment success in patients with benign prostatic enlargement. Urology. 2016;88:161-165. Doi: 10.1016/j. urology.2015.11.029.
Supplementary files
